Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC

INTRODUCTION: Compared to other types of breast cancer, triple-negative breast cancer (TNBC) does not effectively respond to hormone therapy and HER2 targeted therapy, showing a poor prognosis. There are currently a limited number of immunotherapeutic drugs available for TNBC, a field that requires...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Haoming, Feng, Jikun, Zhong, Wenjing, Zouxu, Xiazi, Xiong, Zhengchong, Huang, Weiling, Zhang, Chao, Wang, Xi, Yi, Jiarong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043239/
https://www.ncbi.nlm.nih.gov/pubmed/36999020
http://dx.doi.org/10.3389/fimmu.2023.1151800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043239/
https://www.ncbi.nlm.nih.gov/pubmed/36999020
http://dx.doi.org/10.3389/fimmu.2023.1151800

Ejemplares similares